Vericel Corp VCEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/27/23 EST
28.53UNCH (UNCH)
Volume
5,623
Close
28.53quote price arrow up+0.68 (+2.44%)
Volume
206,958
52 week range
17.30 - 43.97
Loading...
  • Open27.83
  • Day High28.89
  • Day Low27.72
  • Prev Close27.85
  • 52 Week High43.97
  • 52 Week High Date03/03/22
  • 52 Week Low17.30
  • 52 Week Low Date11/09/22

Key Stats

  • Market Cap1.347B
  • Shares Out47.22M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change8.31

KEY STATS

  • Open27.83
  • Day High28.89
  • Day Low27.72
  • Prev Close27.85
  • 52 Week High43.97
  • 52 Week High Date03/03/22
  • 52 Week Low17.30
  • 52 Week Low Date11/09/22
  • Market Cap1.347B
  • Shares Out47.22M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • YTD % Change8.31

RATIOS/PROFITABILITY

  • EPS (TTM)-0.38
  • P/E (TTM)-74.35
  • Fwd P/E (NTM)-117.41
  • EBITDA (TTM)-15.188M
  • ROE (TTM)-10.82%
  • Revenue (TTM)159.262M
  • Gross Margin (TTM)66.29%
  • Net Margin (TTM)-11.36%
  • Debt To Equity (MRQ)0.02%

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vericel Corp

 

Content From Our Affiliates

Profile

MORE
Vericel Corporation is a commercial-stage biopharmaceutical company. The Company is focused on therapies for the sports medicine and severe burn care markets. It markets two autologous cell therapy products in the United States, which include MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple...
Robert Zerbe M.D.
Independent Chairman of the Board
Dominick Colangelo
President, Chief Executive Officer, Director
Michael Halpin
Chief Operating Officer
Joseph Mara
Chief Financial Officer
Jonathan Siegal
Principal Accounting Officer
Address
64 Sidney St
Cambridge, MA
02139-4170
United States

Top Peers

SYMBOLLASTCHG%CHG
ADPT
Adaptive Biotechnologies Corp
9.36+0.15+1.63%
DCPH
Deciphera Pharmaceuticals Inc
17.31-0.67-3.73%
TWST
Twist Bioscience Corp
29.15+1.19+4.26%
SNDX
Syndax Pharmaceuticals Inc
28.14-0.19-0.67%
BBIO
BridgeBio Pharma Inc
9.11+0.26+2.94%